Position in LLY
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$14,835,750
+$3,320,230 QoQ
Shares Held
12,369
-1.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
8.88%
of 13F equity value
Holder Rank
#1,041
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Providence Wealth Advisors, LLC holds $29,228,180 across 9 Drug Manufacturers - General names. LLY ranks #1 (50.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
12,369 | $14,835,750 | |
| 2 | ABBV |
AbbVie Inc.
|
12,831 | $3,228,792 | |
| 3 | JNJ |
Johnson & Johnson
|
10,046 | $2,551,382 | |
| 4 | AMGN |
Amgen Inc
|
6,063 | $2,195,533 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
15,197 | $1,919,988 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
31,560 | $1,818,487 | |
| 7 | MRK |
Merck & Co., Inc.
|
11,036 | $1,418,126 | |
| 8 | PFE |
Pfizer Inc
|
44,086 | $1,061,590 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,835,750 | 12,369 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $11,515,520 | 12,520 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $13,452,845 | 12,518 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $9,648,898 | 12,646 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $9,869,629 | 12,661 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $10,537,785 | 12,759 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $9,626,840 | 12,470 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $11,304,594 | 12,760 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $11,576,188 | 12,786 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $9,939,216 | 12,776 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,389,098 | 2,383 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $6,945,628 | 12,931 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $6,075,635 | 12,955 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $4,483,691 | 13,056 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $4,920,548 | 13,450 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $4,394,649 | 13,591 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,608,280 | 14,213 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $3,975,388 | 13,882 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $3,826,199 | 13,852 | Shares | Sole | 2022-01-12 | |
| 2021-09-30 | $3,221,761 | 13,944 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $3,336,073 | 14,535 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $2,717,110 | 14,544 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $2,432,309 | 14,406 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $2,134,892 | 14,423 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $2,395,057 | 14,588 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $2,009,636 | 14,487 | Shares | Sole | 2020-05-05 | |
| No filing history on record for this holder in this stock. | ||||||